Compare PMT & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PMT | AORT |
|---|---|---|
| Founded | 2009 | 1984 |
| Country | United States | United States |
| Employees | 7 | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 915.6M | 1.1B |
| IPO Year | N/A | 1996 |
| Metric | PMT | AORT |
|---|---|---|
| Price | $10.53 | $22.47 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $13.50 | ★ $49.40 |
| AVG Volume (30 Days) | ★ 975.2K | 753.0K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 13.33% | N/A |
| EPS Growth | N/A | ★ 165.62 |
| EPS | N/A | ★ 0.03 |
| Revenue | N/A | ★ $298,836,000.00 |
| Revenue This Year | N/A | $14.20 |
| Revenue Next Year | $1.55 | $11.20 |
| P/E Ratio | ★ $12.59 | $751.00 |
| Revenue Growth | N/A | ★ 18.01 |
| 52 Week Low | $10.23 | $19.16 |
| 52 Week High | $13.80 | $48.25 |
| Indicator | PMT | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 35.38 | 24.50 |
| Support Level | N/A | $19.16 |
| Resistance Level | $12.82 | $38.43 |
| Average True Range (ATR) | 0.28 | 1.88 |
| MACD | -0.05 | -0.49 |
| Stochastic Oscillator | 16.04 | 18.89 |
PennyMac Mortgage Investment Trust is a specialty finance company that invests mainly in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.